COMPARISON OF RSV HOSPITALISATION IN PRETERM INFANTS WITH CHRONIC LUNG DISEASE WHO DO NOT QUALIFY FOR PALIVIZUMAB PROPHYLAXIS WITH THOSE WHO QUALIFY IN NOTTINGHAM, UK

Tsilika L.; Batra D.; Prayle A. P.; Hurley M.; Bhatt J. M.

首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >COMPARISON OF RSV HOSPITALISATION IN PRETERM INFANTS WITH CHRONIC LUNG DISEASE WHO DO NOT QUALIFY FOR PALIVIZUMAB PROPHYLAXIS WITH THOSE WHO QUALIFY IN NOTTINGHAM, UK

【24h】

COMPARISON OF RSV HOSPITALISATION IN PRETERM INFANTS WITH CHRONIC LUNG DISEASE WHO DO NOT QUALIFY FOR PALIVIZUMAB PROPHYLAXIS WITH THOSE WHO QUALIFY IN NOTTINGHAM, UK

机译：RSV住院治疗早产儿的慢性肺病，慢性肺病患者不符合帕尔廷沙姆，英国诺丁汉的人有资格

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thorax: The Journal of the British Thoracic Society》 |2017年第3期|共1页
作者
Tsilika L.; Batra D.; Prayle A. P.; Hurley M.; Bhatt J. M.;
展开▼
作者单位

Nottingham Childrens Hosp Nottingham England;

Nottingham Childrens Hosp Nottingham England;

Nottingham Childrens Hosp Nottingham England;

Nottingham Childrens Hosp Nottingham England;

Nottingham Childrens Hosp Nottingham England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
专利

1. COMPARISON OF RSV HOSPITALISATION IN PRETERM INFANTS WITH CHRONIC LUNG DISEASE WHO DO NOT QUALIFY FOR PALIVIZUMAB PROPHYLAXIS WITH THOSE WHO QUALIFY IN NOTTINGHAM, UK [J] . Tsilika L., Batra D., Prayle A. P., Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：RSV住院治疗早产儿的慢性肺病，慢性肺病患者不符合帕尔廷沙姆，英国诺丁汉的人有资格
2. Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis [J] . Cetinkaya M., Oral T. K., Karatekin S., European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology . 2017,第9期

机译：Palivizumab预防对早产儿RSV相关的下呼吸道感染频率的疗效：测定预防的理想靶群
3. Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis [J] . Carbonell-EstranyX., FullartonJ.R., GoochK.L., The journal of maternal-fetal & neonatal medicine . 2013,第9期

机译：父母和家庭吸烟对晚期早产儿呼吸道合胞病毒（RSV）住院风险的影响以及RSV预防的潜在影响
4. Pre- and post-natal inflammatory events in chronic lung disease of preterm infants [C] . Christian P SPEER Acta pharmacologica sinica . 2002

机译：早产儿慢性肺疾病的产前和产后炎症事件
5. Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants [O] . Gaetano Chirico, Roberto Ravasio, Urbano Sbarigia 2020

机译：意大利帕利珠单抗的成本-效用分析：预防高危早产儿呼吸道合胞病毒感染（RSV）的模拟模型的结果
6. Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports [O] . Renato Cutrera, Andrea Wolfler, Simonetta Picone, 2019

机译：2014年美国儿科院校建议的影响以及由意大利药物对2016-2017流行病季节的早产儿婴儿的RSV相关住院课程的意大利药物局的影响有限的财务报告：对七个意大利报告的系统审查

COMPARISON OF RSV HOSPITALISATION IN PRETERM INFANTS WITH CHRONIC LUNG DISEASE WHO DO NOT QUALIFY FOR PALIVIZUMAB PROPHYLAXIS WITH THOSE WHO QUALIFY IN NOTTINGHAM, UK

著录项

相似文献

相关主题

期刊订阅